EP 0641212 A1 19950308 - METHOD AND REAGENT FOR INHIBITING CANCER DEVELOPMENT.
Title (en)
METHOD AND REAGENT FOR INHIBITING CANCER DEVELOPMENT.
Title (de)
VERFAHREN UND WIRKSTOFF ZUR HEMMUNG DER KREBSENTWICKLUNG.
Title (fr)
PROCEDE ET REACTIF DESTINES A EMPECHER L'EVOLUTION DU CANCER.
Publication
Application
Priority
- US 9304573 W 19930513
- US 88282292 A 19920514
- US 88288592 A 19920514
- US 93611092 A 19920826
- US 93642192 A 19920826
- US 93642292 A 19920826
- US 93653192 A 19920826
- US 93653292 A 19920826
- US 98713192 A 19921207
- US 612293 A 19930119
- US 891093 A 19930119
Abstract (en)
[origin: WO9323057A1] An enzymatic RNA molecule which specifically cleaves mRNA encoded by an mdr-1 gene, or associated with development or maintenance of chronic myelogenous leukemia, promyelocytic leukemia, Burkitt's lymphoma or acute lymphocytic leukemia, follicular lymphoma, B-cell acute lymphocytic leukemia, breast cancer, colon carcinoma, neuroblastoma, and lung cancer.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 31/70 (2006.01); A61K 48/00 (2006.01); A61P 31/12 (2006.01); C07H 19/10 (2006.01); C07H 21/02 (2006.01); C12N 5/16 (2006.01); C12N 15/113 (2010.01); C12N 15/63 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61P 31/12 (2017.12); C12N 15/113 (2013.01); C12N 15/1135 (2013.01); C12N 15/1138 (2013.01); A61K 38/00 (2013.01); C12N 2310/111 (2013.01); C12N 2310/121 (2013.01); C12N 2310/122 (2013.01); C12N 2310/123 (2013.01); C12N 2310/124 (2013.01); C12N 2310/126 (2013.01); C12N 2310/53 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9323057 A1 19931125; AU 4248993 A 19931213; AU 687001 B2 19980219; CA 2135499 A1 19931125; EP 0641212 A1 19950308; EP 0641212 A4 19970521; JP H08502950 A 19960402
DOCDB simple family (application)
US 9304573 W 19930513; AU 4248993 A 19930513; CA 2135499 A 19930513; EP 93911311 A 19930513; JP 50093993 A 19930513